ICAD INC. - COMMON STOCK

iCAD to Report Fourth Quarter and Full Year 2023 Financial Results on March 12, 2024

27 2 2024 07:05:00 提供 Nasdaq GlobeNewswire

iCAD to Participate in the BTIG at Snowbird: 11th Annual MedTech, Digital Health, Life Science & Diagnostic Tools Conference

06 2 2024 07:00:01 提供 Nasdaq GlobeNewswire

iCAD Expands Board of Directors with Appointment of Michael J. Doyle, FACHE as New Board Member

30 1 2024 07:00:00 提供 Nasdaq GlobeNewswire

iCAD Expands Executive Sales Leadership Team as Business Grows

18 12 2023 07:00:00 提供 Nasdaq GlobeNewswire

iCAD’s ProFound AI Can Predict 1-2 Year Risk for Breast Cancer and Reveal Insights for Heart Disease

27 11 2023 07:00:00 提供 Nasdaq GlobeNewswire

iCAD and CancerIQ Announce Partnership to Integrate AI-Enabled Technology With Best-in-Class Risk Assessment and Care Management Platform Offering A Comprehensive Breast Health Care Solution  

20 11 2023 07:00:00 提供 Nasdaq GlobeNewswire

iCAD to Participate in the 14th Annual Craig-Hallum Alpha Select Conference

14 11 2023 07:00:00 提供 Nasdaq GlobeNewswire

iCAD Reports Financial Results for Third Quarter Ended September 30, 2023

13 11 2023 15:01:00 提供 Nasdaq GlobeNewswire

iCAD to Report Third Quarter 2023 Financial Results on November 13, 2023

30 10 2023 07:00:00 提供 Nasdaq GlobeNewswire

iCAD, Inc. Announces Sale of Xoft, its Brachytherapy Business Line, to Elekta

23 10 2023 07:01:00 提供 Nasdaq GlobeNewswire

Health Canada Grants Device License for iCAD's ProFound Risk 2.0, Revolutionizing Breast Cancer Risk Via a 1-2 Year Assessment

16 8 2023 07:00:00 提供 Nasdaq GlobeNewswire

iCAD Reports Financial Results for Second Quarter Ended June 30, 2023 

14 8 2023 15:01:00 提供 Nasdaq GlobeNewswire

iCAD and Google Health Expand Integration of Google’s AI Technology with iCAD’s ProFound Breast Health Suite for 2D Mammography for Use as Independent Reader

14 8 2023 07:00:00 提供 Nasdaq GlobeNewswire

iCAD to Report Second Quarter 2023 Financial Results on August 14, 2023

31 7 2023 07:00:00 提供 Nasdaq GlobeNewswire

iCAD Signs Strategic Commercial Agreement with Radiology Partners, the Nation’s Largest Radiology Practice

18 7 2023 07:00:01 提供 Nasdaq GlobeNewswire

iCAD’s “ProFound Insights, ProFound Impact” Webinar Series to Feature Cleveland Clinic

12 7 2023 07:00:00 提供 Nasdaq GlobeNewswire

iCAD Offers ROI Analysis Based on Real-World Results from its ProFound Breast AI Suite at AHRA Annual Meeting

10 7 2023 07:00:00 提供 Nasdaq GlobeNewswire

iCAD’s ProFound AI Breast Suite Wins U.S. General Services Administration’s AI Healthcare Challenge Award

18 5 2023 07:00:00 提供 Nasdaq GlobeNewswire

iCAD Reports Financial Results for First Quarter Ended March 31, 2023

15 5 2023 15:01:00 提供 Nasdaq GlobeNewswire

New Long-Term Real-World Research Confirms Xoft Skin eBx is as Safe and Effective as Mohs Surgery

11 5 2023 07:00:01 提供 Nasdaq GlobeNewswire